Key facts
- Notable investors include GL Ventures, Plum Ventures, Source Code Capital, Vision Plus Capital, Xiamen Venture Capital — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Aires (Therapeutic Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for Aires (Therapeutic Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aires (Therapeutic Devices)
Manufacturer of contact lenses and colored lenses intended for clinical correction and daily cosmetic wear. The company provides end-to-end eyewear fabrication and Class III medical device production and sales, providing consumers with access to safe and reliable vision-care solutions.
- Sector
- Healthcare
- HQ
- Xiamen, China
- Founded
- 2020
- Website
- iris-amoi.com/
- Ownership
- Privately Held (backing)
Aires (Therapeutic Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aires (Therapeutic Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aires (Therapeutic Devices) in its N-PORT filings yet. We sweep new filings monthly.